This session will address FDA’s enforcement discretion, including what it is an how it has been utilized by FDA during the COVID-19 health emergency. Ways to protect your company from liability considerations will also be discussed.
Sonali P. Gunawardhana, Of Counsel, Shook, Hardy & Bacon LLP
Angela M. Seaton, Partner, Shook, Hardy & Bacon LLP
This session was recorded as part of FDLI’s virtual course, “COVID-19: Introduction to FDA’s Existing Legal Authorities and Emerging Issues” on August 18, 2020.